Powell Industries: A Golden Buying Opportunity After Recent Pullback — Positive
POWL Seeking Alpha — February 13, 2025Powell Industries reported a 24.4% year-on-year revenue increase to $241.1 million in Q1 FY25, despite moderated growth in core markets like petrochemicals and oil and gas. Strong order activity across the end markets and benefits from robust backlog and expanded capacity should fuel topline growth in FY25. Anticipated volume growth and benefits from focus on operational improvements are expected to support margins in the quarters ahead.

Lost Money on Innovative Industrial Properties, Inc. (IIPR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky — Neutral
IIPR Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=129305&wire=1 or contact Joseph E. Levi, Esq.

Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT — Neutral
APLT Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=129315&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR — Neutral
ICLR Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=129317&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Announces an Investigation on Behalf of Electronic Arts Inc. (EA) Shareholders Who May Have Been Affected by Fraud — Neutral
EA Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Electronic Arts Inc. ("Electronic Arts Inc.") (NASDAQ:EA) concerning possible violations of federal securities laws. On January 22, 2025, EA issued a press release pre-announcing their preliminary Q3 FY25 results and announcing a guide-down from the company's prior expectations.

Crocs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 24, 2025 to Discuss Your Rights - CROX — Neutral
CROX Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=129316&wire=1 or contact Joseph E. Levi, Esq.

Grocery Outlet Holding Corp. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - GO — Neutral
GO Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=129308&wire=1 or contact Joseph E. Levi, Esq.

Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against Neumora Therapeutics, Inc. (NMRA) — Neutral
NMRA Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=129306&wire=1 or contact Joseph E. Levi, Esq.

NTLA LAWSUIT ALERT: Levi & Korsinsky Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline — Neutral
NTLA Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=129319&wire=1 or contact Joseph E. Levi, Esq.

Shareholders of AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN — Neutral
AZN Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=129328&wire=1 or contact Joseph E. Levi, Esq.

Lost Money on FTAI Aviation Ltd. (FTAI)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky — Neutral
FTAI Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=129331&wire=1 or contact Joseph E.

Mullen Automotive Inc. Announces Reverse Stock Split Effective Feb. 18, 2025 — Neutral
MULN GlobeNewsWire — February 13, 2025BREA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announced today that it will effect a 1-for-60 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.001 per share (“Common Stock”), that will become effective on Feb. 18, 2025, at 12:01 a.m. Eastern Time. The Common Stock will continue to trade on The Nasdaq Capital Market (“Nasdaq”) under the existing symbol MULN and will begin trading on a split-adjusted basis when the market opens on Feb. 18, 2025. The new CUSIP …

Shareholders that Lost Money on Caribou Biosciences, Inc. (CRBU) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
CRBU Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=129333&wire=1 or contact Joseph E. Levi, Esq.

Nextracker Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 25, 2025 to Discuss Your Rights - NXT — Neutral
NXT Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129326&wire=1 or contact Joseph E. Levi, Esq.

Harmonic Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HLIT — Neutral
HLIT Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.

Pacira BioSciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX — Neutral
PCRX Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=129330&wire=1 or contact Joseph E. Levi, Esq.

Investors Who Lost Money on Regeneron Pharmaceuticals, Inc. (REGN) Should Contact Levi & Korsinsky About Pending Class Action - REGN — Neutral
REGN Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=129320&wire=1 or contact Joseph E. Levi, Esq.

February 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - RIG — Neutral
RIG Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=129321&wire=1 or contact Joseph E.

Johnson & Johnson halts late-stage E.coli vaccine trial after poor results — Negative
JNJ New York Post — February 13, 2025Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary effectiveness thresholds.

Gilat's Q4 Earnings Surpass Estimates, Revenues Lag, Stock Tanks — Positive
GILT Zacks Investment Research — February 13, 2025GILT's fourth-quarter 2024 performance reflects expanding momentum in the defense and IFC sectors, backed by increasing deal wins.
